The PREPARE Study: Acceptability and Feasibility of a Telehealth Trimodal Prehabilitation Program for Women with Endometrial Neoplasia
Current Oncology · 2025
DOI: 10.3390/curroncol32010055 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, 2025. Verfasst von Elise P Legault und 7 weiteren Autor:innen. Beteiligte Einrichtung: Coeurlab Research Unit, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, QC H2X 0A9, Canada. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Preoperative Care. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Digitalisierung in der Pflege
Abstract (Originalsprache)
Patients with endometrial neoplasia (EN) often have multiple comorbidities and a higher surgical risk. Prehabilitation programs (PPs) combine various interventions to improve preoperative conditions and reduce impairment due to surgical stress. We conducted a pragmatic pilot study to evaluate the acceptability and feasibility of a trimodal telehealth PP (exercise, nutrition, and psychological support) for EN patients. The participants could select their exercise group: (1) a supervised PP (SPP), group sessions 3×/week; (2) a semi-supervised PP (SSPP), group session 1×/week, training alone 2×/week; or (3) a physical activity counseling session (PACS). Out of the 150 EN patients awaiting surgery screened during the 18 months of the study recruitment, 66% (99/150) were eligible, and 40% consented to participate (SPP, n = 13; SSPP, n = 17; PACS, n = 9). The overall dropout was low (13%; 5/39), with no significant differences across groups. No serious adverse events occurred. We observed a positive impact on different outcomes across the different groups, such as in the Functional Assessment of Cancer Therapy quality of life score (SPP; delta = 6.1 [CI: 0.9; 12.6]) and functional capacity measured using the 30″ sit-to-stand test (PACS delta = 2.4 [CI: 1.2; 3.6]). The same-day hospital leave was high in the SSPP group (54.5%). Our pilot telehealth PP seems to be safe, feasible, and well accepted and may procure clinical and patient-centered gains that need to be confirmed in a larger trial.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Coeurlab Research Unit, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, QC H2X 0A9, Canada.
- Département des Sciences de l'Activité Physique, Université du Québec à Montréal, Montréal, QC H2L 1Y4, Canada.
- Service de Gynécologie Oncologique du Centre Hospitalier de l'Université de Montréal, Montréal, QC H2X 0C1, Canada.
- Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC H2X 0A9, Canada.
- Département d'Obstétrique-Gynécologie, Université de Montréal, Montréal, QC H3C 3J7, Canada.
- Service de Cardiologie du Centre Hospitalier de l'Université de Montréal, Montréal, QC H2X 0C1, Canada.
ORCID-Profile: Elise P Legault, Paula A B Ribeiro, Sara Forte, Alain S Comtois, François Tournoux
Zitieren
APA
Legault, E. P., Ribeiro, P. A. B., Moreau-Amaru, D., Robert, E., Forte, S., Comtois, A. S., Samouëlian, V., & Tournoux, F. (2025). The PREPARE Study: Acceptability and Feasibility of a Telehealth Trimodal Prehabilitation Program for Women with Endometrial Neoplasia. Current Oncology. https://doi.org/10.3390/curroncol32010055
Vancouver
Legault EP, Ribeiro PAB, Moreau-Amaru D, Robert E, Forte S, Comtois AS, et al. The PREPARE Study: Acceptability and Feasibility of a Telehealth Trimodal Prehabilitation Program for Women with Endometrial Neoplasia. Current Oncology. 2025. doi:10.3390/curroncol32010055
BibTeX
@article{Legault2025,
author = {Legault, Elise P and Ribeiro, Paula A B and Moreau-Amaru, Danielle and Robert, Emmanuelle and Forte, Sara and Comtois, Alain S and Samouëlian, Vanessa and Tournoux, François},
title = {The PREPARE Study: Acceptability and Feasibility of a Telehealth Trimodal Prehabilitation Program for Women with Endometrial Neoplasia},
journal = {Current Oncology},
year = {2025},
doi = {10.3390/curroncol32010055}
}
EUVIMED